US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Radiodermatitis - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... Radiodermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Thrombocytopenia - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... Thrombocytopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Pressure Ulcers Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... line data relating to the clinical trials on Pressure Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Vitiligo Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... to the clinical trials on Vitiligo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
Pompe Disease Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... line data relating to the clinical trials on Pompe Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Epistaxis Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... to the clinical trials on Epistaxis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
Pneumonia Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... to the clinical trials on Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
Joint Pain Global Clinical Trials Review, H1, 2015
6/25/2015 | published by: GlobalData
... line data relating to the clinical trials on Joint Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Hernia Global Clinical Trials Review, H1, 2015
6/25/2015 | published by: GlobalData
... to the clinical trials on Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
Streptococcus Pneumoniae Infection - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... information on the therapeutic development for Streptococcus Pneumoniae Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Pseudomonas Aeruginosa Infections - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... information on the therapeutic development for Pseudomonas Aeruginosa Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Osteoporosis - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Ischemia - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Atopic Dermatitis - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... therapeutic development for Atopic Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Pharmaceutical Industry in China to 2020: An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
7/1/2015 | published by: Kelly Scientific Publications
... segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 265 tables & figures within 182 pages. The Chinese biopharmaceutical market is presented as follows: By ...  |  read more...
USD 3,400
Acne Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 670
Acute Ischemic Stroke Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... It covers emerging therapies for Acute Ischemic Stroke in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 670
Acute Lymphocytic Leukemia Pipeline Highlights – 2015 Update
7/1/2015 | published by: Fore Pharma
... It covers emerging therapies for Acute Lymphocytic Leukemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 670
Dermatology Pipeline Highlights Database – 2015 Update
7/1/2015 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Impetigo, Atopic Dermatitis, Psoriasis, Erythema multiforme, Alopecia Areata, Acne, and Rosacea. The pipeline data is presented ...  |  read more...
USD 2,800
Ophthalmology Pipeline Highlights Database – 2015 Update
7/1/2015 | published by: Fore Pharma
... disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Conjunctivitis, Glaucoma, Diabetic Retinopathy, Myasthenia gravis, Dry Eye Syndrome, Age-related Macular Degeneration, and Cataract. The ...  |  read more...
USD 2,800
Blood Disorders Pipeline Highlights Database – 2014
7/1/2015 | published by: Fore Pharma
... for Blood Disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Neutropenia, Sickle-cell Disorders, Thalassemia, Iron deficiency anemia, Haemophilia A, and Haemophilia B. The ...  |  read more...
USD 2,800
Gastrointestinal Disorders Pipeline Highlights Database – 2014
7/1/2015 | published by: Fore Pharma
... for Gastrointestinal Disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Gastro-esophageal reflux disease (GERD), Gastric ulcer, Peptic ulcer, Crohn's disease, Ulcerative colitis, and ...  |  read more...
USD 2,800
Oncology Pipeline Highlights Database – 2014
7/1/2015 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Esophageal Cancer Stomach Cancer, Colon Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical Cancer, Ovary Cancer, ...  |  read more...
USD 2,800
Central Nervous System Disorders Pipeline Highlights Database – 2015 Update
7/1/2015 | published by: Fore Pharma
... (CNS) disorders Drug market. It covers emerging therapies for CNS indications in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Multiple Sclerosis, Depression, Alzheimer’s disease, ...  |  read more...
USD 2,800
Cancer Drugs in the FDA Fast Lane Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... of new drugs, ranging from Fast track (1988), Accelerated approval (1992), Priority review (1992) to the most recent Breakthrough therapy (2012). This pipeline update, Cancer Drugs in the FDA Fast Lane, gives a thorough account ...  |  read more...
USD 4,485
6  7  8  9    11    13  14  15